Tarka en es it fr

Tarka Brand names, Tarka Analogs

Tarka Brand Names Mixture

  • No information avaliable

Tarka Chemical_Formula


Tarka RX_link

No information avaliable

Tarka fda sheet

Tarka msds (material safety sheet)

Tarka Synthesis Reference

No information avaliable

Tarka Molecular Weight

329.433 g/mol

Tarka Melting Point

264 oC

Tarka H2O Solubility

No information avaliable

Tarka State


Tarka LogP


Tarka Dosage Forms


Tarka Indication

Used in the treatment of Cushing's syndrome. It is normally used in short-term treatment until permanent therapy is possible.

Tarka Pharmacology

Trilostane blocks an enzyme involved in the production of several steroids including cortisol. Inhibiting this enzyme inhibits the production of cortisol. In Cushing's syndrome, the adrenal gland overproduces steroids. Although steroids are important for various functions of the body, too much can cause problems. Trilostane reduces the amount of steroids produced by the adrenal gland. This product was withdrawn from the U.S. market in April 1994.

Tarka Absorption

No information avaliable

Tarka side effects and Toxicity

Symptoms of overdose include darkening of skin, drowsiness or tiredness, loss of appetite, mental depression, skin rash, and/or vomiting.

Tarka Patient Information

No information avaliable

Tarka Organisms Affected

Humans and other mammals